Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line

Molecular and Cellular Biochemistry

Volumn 306, Issue 1-2, 2007, Pages 201-212

  Christgen, Matthias ^a   Ballmaier, Matthias ^a   Bruchhardt, Henriette ^a   Wasielewski, Reinhard ^a   Kreipe, Hans ^a   Lehmann, Ulrich ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

BCRP1; Cal51; Cancer stem cells; Differentiation; Intratumoral heterogeneity

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MUCIN 1;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; WESTERN BLOTTING;

ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; FEMALE; FLOW CYTOMETRY; HUMANS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 35548932425     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-007-9570-y     Document Type: Article

References (33)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983-3988
2. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65:5506-5511
3. Liu S, Dontu G, Mantle ID, Patel S, Ahn N, Jackson KW, Suri P, Wicha MS (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66:6063-6071
4. Liu BY, McDermott SP, Khwaja SS, Alexander CM (2004) The transforming activity of Wnt effectors correlates with their ability to induce accumulation of mammary progenitor cells. Proc Natl Acad Sci USA 101:4158-4163
5. Scharenberg CW, Harkey MA, Torok-Storb B (2002) The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99:507-512
6. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17:1253-70
7. Alvi AJ, Clayton H, Joshi C, Enver T, Ashworth A, Vivanco M, Dale TC, Smalley MJ (2003) Functional and molecular characterization of mammary side population cells. Breast Cancer Res 5:R1-R8
8. Clarke R, Spence K, Anderson E, Howell A, Okano H, Potten CS (2005) A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev Biol 277:443-456
9. Behbod F, Xian W, Shaw CA, Hilsenbeck SG, Tsimelzon A, Rosen JM (2006) Transcriptional profiling of mammary gland side population cells. Stem cells 24:1065-1074
10. Jonker JW, Freeman J, Bolscher E, Musters S, Alvi AJ, Titley I, Schinkel AH, Dale TC (2005) Contribution of the ABCG2 Transporters Bcrp1 and Mdr1a/1b to the side population phenotype in mammary gland and bone marrow of mice. Stem cells 23:1059-1065
11. Jonker JW, Merino G, Musters S, van Herwaarden AE, Bolscher E, Wagenaar E, Mesman E, Dale TC, Schinkel AH (2005) The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat Med 11:127-129
12. Challen GA, Little MH (2006) A side order of stem cells: The SP phenotype. Stem cells 24:3-12
13. Kim M, Turnquist H, Jackson J, Sgagias M, Yan Y, Gong M, Dean M, Sharp JG, Cowan K (2002) The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes H33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 8:22-28
14. Kondo T, Setoguchi T, Taga T (2004) Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 101:781-786
15. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, Goodell MA, Brenner MK (2004) A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101:14228-14233
16. + and ABCG2 - cancer cells are similarly tumorigenic. Cancer Res 65:6207-6219
17. Haraguchi N, Utsunomiya T, Inoues H, Tanaka F, Mimori K, Barnard GH, Mori M (2006) Characterization of a side population of cancer cells from human gastrointestinal system. Stem cells 24:506-513
18. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, MacLaughlin DT, Donahoe PK (2006) Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA 103:11154-11159
19. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, Nakauchi H, Taniguchi H (2006) Side population purified from hepatocellular carcinoma harbours cancer stem cell-like properties. Hepatology 44:240-251
20. Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, Rosen JM (2007) WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA 104:618-623
21. Mitsutake N, Iwao A, Nagai K, Namba H, Ohtsuru A, Saenko V, Yamashita S (2007) Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology 148:1797-1803
22. Hill RP (2006) Identifying cancer stem cells in solid tumors: Case not proven. Cancer Res 66:1891-1896
23. Setoguchi T, Taga T, Kondo T (2004) Cancer stem cells persist in many cancer cell lines. Cell Cycle 3:414-415
24. Locke M, Heywood M, Fawell S, Mackenzie IC (2005) Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res 65:8944-8950
25. Böcker W, Moll R, Poremba C, Holland R, vanDiest PJ, Dervan P, Burger H, Wai D, Diallo RI, Brand B, Herbst H, Schmidt A, Lerch MM, Buchwallow IB. (2002) Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: A new cell biological concept. Lab Invest 82:737-745
26. Uphoff CC, Drexler HG (2005) Detection of mycoplasma contamination. Methods Mol Biol 290:13-23
27. von Wasilewski R, Mengel M, Gignac S, Wilkens L, Werner M, Georgii A (1997) Tyramine amplification technique in routine immunohistochemistry. J Histochem Cytochem 45:1455-1459
28. Diestra JE, Scheffer GL, Catala I, Maliepaard M, Schellens JHM, Scheper RJ, Gema-Lluch JR, Izquierdo MA (2002) Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. J Pathol 198:213-219
29. Rabindran SK, Ross DD, Doyle LA, Yang W, Greenberger LM (2000) Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res 60:47-50
30. Ifergan I, Scheffer GL, Assaraf YG (2005) Novel extracellular vesicles mediate an ABCG2-dependent anticancer drug sequestration and resistance. Cancer Res 65:10952-10958
31. Olempska M, Eisenach PA, Ammerpohl O, Ungefroren H, Fandrich F, Kalthoff H (2007) Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Int 6:92-97
32. Nakanishi T, Bailey-Dell KJ, Hassel BA, Shiozawa K, Sullivan DM, Turner J, Ross DD (2006) Novel 5′ UTR region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: Implication for drug resistance, tissue-specific expression and alternative promotor usage. Cancer Res 66:5007-5011
33. Imai Y, Ishikawa E, Asada S, Sugimoto Y (2005) Estrogen-mediated post-transcriptional down-regulation of breast cancer resistance protein/ ABCG2. Cancer Res 65:596-604